NEMO: A Novel Prognostic Model of Non-Icans Neurotoxicities Associated with Ciltacabtagene AutoleucelYein Jeon, Jordan Gauthier, Madhav Vishnu Dhodapkar et al.|Transplantation and Cellular Therapy|2026Cited by 0
Outcomes of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS) in Patients Receiving Frontline Anakinra and CorticosteroidsEmily C. Liang, Jordan Gauthier, Dwight C Macero et al.|Transplantation and Cellular Therapy|2026Cited by 0
Comprehensive Benchmarking of Outcomes after Anakinra Treatment for Refractory Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)Smith Kungwankiattichai, Jordan Gauthier, Emily C. Liang et al.|Transplantation and Cellular Therapy|2026Cited by 0
Idiopathic Post-CAR-T Hypotension: Prevalence and Management with Midodrine and/or FludrocortisoneChristy Khouderchah, Mazyar Shadman, Lawrence Fong et al.|Transplantation and Cellular Therapy|2026Cited by 0
ALC Kinetics Velocity and Acceleration Are Early Predictors of Non-Icans Neurotoxicities after Cilta-Cel TreatmentYein Jeon, Jordan Gauthier, Xiancheng Wu et al.|Transplantation and Cellular Therapy|2026Cited by 0